How Serious Is a Subchondral Fracture?

Subchondral fractures vary greatly in seriousness. Discover the factors—like joint stability and cartilage damage—that determine prognosis and long-term joint health risks.

Subchondral fractures range from injuries that heal quietly on their own to fractures that destroy a joint within months, so their seriousness depends heavily on the size of the fracture, whether the joint surface has collapsed, and which joint is involved. In the knee, these fractures are a common and often underrecognized cause of sudden pain in older adults. The best evidence suggests that small, early-stage subchondral fractures frequently resolve with conservative care, while larger fractures or those that progress to bone death can lead to rapid joint deterioration requiring surgery. Understanding where a particular fracture falls on that spectrum is the key to knowing how worried you should be.

What a Subchondral Fracture Actually Is

Just beneath the smooth cartilage that lines your joints sits a thin, dense plate of bone called the subchondral bone. This layer acts as a structural foundation for cartilage and plays a critical role in absorbing and distributing mechanical loads during movement. Research on impact compression shows that both cartilage and subchondral bone absorb shock, but when the bone fractures under load, it absorbs significantly more energy, which may spare the cartilage from immediate damage but sets the stage for longer-term joint problems. Subchondral bone’s contribution to overall joint health is often underappreciated, but it is now recognized as a central player in both injury response and the development of osteoarthritis.

A subchondral fracture occurs when this bone cracks, either from a single traumatic impact or, more commonly in clinical practice, from repetitive stress on weakened bone. That second type, called a subchondral insufficiency fracture, happens when normal or only slightly excessive forces are applied to bone that is already fragile. Think of it as a stress fracture that occurs right beneath the cartilage surface, often without any specific injury the patient can recall.

How These Fractures Show Up

The hallmark symptom is sudden onset of joint pain without a clear traumatic event. In the hip, patients typically describe acute hip pain that seems to come out of nowhere. In the knee, the pain tends to localize to one side of the joint and worsens with weight-bearing. Subchondral insufficiency fractures of the knee are a common cause of joint pain in older adults, resulting from repetitive and excessive stress on the subchondral bone.

One reason these fractures are considered serious is that they are easy to miss early on. The pain can mimic a meniscal tear, a flare of osteoarthritis, or even referred pain from the spine. Many patients and physicians initially attribute the symptoms to a “bad knee day” rather than a fracture. By the time imaging catches the problem, weeks or months may have passed, and the fracture may have progressed.

Why MRI Matters So Much

Standard X-rays can miss subchondral fractures, especially in their early stages. MRI is the imaging tool of choice because it can detect the bone marrow swelling that surrounds these fractures long before any structural collapse is visible on X-ray. The characteristic MRI finding is a low-signal line in the subchondral bone surrounded by extensive bone marrow edema.

Interestingly, for subchondral fractures specifically related to osteonecrosis of the femoral head, the sensitivity of different imaging methods tells a complicated story. One study comparing MRI, CT, and plain radiography found that MRI had a sensitivity of only about 38% for detecting the subchondral fracture line itself, while plain radiography actually performed better at around 71%, though MRI had perfect specificity at 100%. That said, MRI remains the go-to for early detection because its ability to show bone marrow edema helps catch the problem before the fracture line becomes clearly visible. What this means practically is that if your doctor suspects a subchondral fracture, an MRI is almost always warranted, even if your X-ray looks normal.

The tissue changes underlying MRI findings are real and consequential. In regions that light up as bone marrow edema on MRI, studies have found infiltration of the marrow by fibrous tissue and evidence of increased bone remodeling, and these changes are specifically localized beneath areas where the overlying cartilage is breaking down. The marrow edema on MRI is not just a signal anomaly; it represents real biological disruption happening inside the bone.

What Determines Whether the Fracture Is Mild or Devastating

This is where the question of seriousness gets its most concrete answers. Several measurable features on imaging predict whether a subchondral fracture will heal or progress to joint destruction. Research comparing low-grade and high-grade subchondral insufficiency fractures of the knee found that the following features were strongly associated with worse outcomes: the presence of a meniscal tear, the degree of meniscal extrusion, existing cartilage damage, involvement of the medial femoral condyle, surface collapse, and the overall dimensions of the fracture on MRI. Whether the bone marrow edema improved on follow-up imaging was also a strong predictor, with persistent or worsening edema signaling trouble.

For the hip, similar patterns hold. A study of subchondral insufficiency fractures of the femoral head found that patients who eventually needed a total hip replacement had significantly larger cartilage defects overlying the fracture (averaging around 29 mm versus 10 mm in those who did not need surgery), larger fracture dimensions, and were more likely to be male and older. In that study, roughly half of patients required total hip arthroplasty at an average of six months after the MRI that detected the fracture.

In practical terms, a small subchondral fracture with no surface collapse, minimal surrounding edema, and no associated meniscal or cartilage damage is a very different animal from a large fracture with joint surface collapse and extensive cartilage loss. The first may heal uneventfully. The second may end in joint replacement.

The Two Tracks After a Subchondral Fracture

One of the most clinically important things to understand is that subchondral insufficiency fractures can follow two very different paths. In the early stages, both paths look similar on MRI: you see bone marrow edema beneath the cartilage. But the outcomes diverge sharply. Many subchondral insufficiency fractures heal spontaneously. However, some evolve into osteonecrosis, where the bone tissue actually dies, leading to irreversible collapse of the joint surface.

The condition previously known as “spontaneous osteonecrosis of the knee” (SONK) is now understood to actually begin as a subchondral insufficiency fracture that fails to heal and progresses to bone death. This reclassification matters because it changes how aggressively the fracture should be treated. If a fracture that might heal on its own is treated too aggressively, you expose the patient to unnecessary surgical risk. If a fracture heading toward collapse is treated too conservatively, you may lose the window to preserve the joint.

When the fracture does progress, the consequences are severe. Subchondral fractures have been implicated in several destructive joint conditions whose causes were previously poorly understood, including rapidly progressive osteoarthritis of the hip and distal clavicular osteolysis. Joint destruction in these cases can unfold over just weeks to months. Progressive subchondral fracture leads to joint collapse and secondary osteoarthritis and is associated with underlying osteoporosis. In the hip specifically, subchondral insufficiency fracture resulting from weakened bone can lead to rapid breakdown of the joint.

Risk Factors That Increase Your Vulnerability

Not everyone is equally at risk. The combination of osteoporosis and osteoarthritis creates a particularly dangerous environment for the subchondral bone. When both conditions are present, the bone shows significantly lower density, fewer and thinner structural struts, and nearly 70% more microdamage compared to osteoarthritis alone. The stress within the bone also becomes more concentrated and unevenly distributed.

Meniscal problems are another major risk factor. The meniscus acts as a shock absorber and load distributor in the knee, so when it is torn or pushed out of position, the subchondral bone underneath takes a beating. Research has found that medial meniscus extrusion is significantly greater in patients with subchondral insufficiency fractures compared to those without, and both meniscal injuries and pathological extrusion are more common in the fracture group. If you have a known meniscal tear and are developing new pain in the same area, a subchondral fracture should be on the differential.

Other factors that raise risk include older age, female sex (largely because of postmenopausal bone loss), use of corticosteroids, and varus alignment of the knee, which concentrates forces on the inner side of the joint. Kidney disease and other conditions that weaken bone quality also play a role.

Conservative Treatment and When It Works

For early-stage, low-grade subchondral fractures without surface collapse, conservative management is the first approach. This typically involves restricting weight-bearing for an extended period, sometimes supplemented with medications to address underlying bone weakness. One case demonstrated that a combination of restricted weight-bearing and bisphosphonate infusions (given to treat osteoporosis detected on a bone density scan) led to complete resolution of an insufficiency fracture of the medial femoral condyle within about four and a half months.

Bisphosphonates, which slow bone breakdown and can strengthen weakened bone, show particular promise. A review of the evidence found that the majority of bisphosphonate studies describe beneficial effects including shrinkage of the fracture on imaging, reduced pain, faster healing, and improved function. That said, the literature also reports a high rate of adverse effects at around 47%, though the nature and severity of those side effects vary. Significant clinical improvements were seen in roughly two-thirds to all patients studied.

The recovery timeline for conservative treatment is often longer than patients expect. One documented case of a subchondral insufficiency fracture of the knee required partial weight-bearing on crutches for 14 months. The patient also received viscosupplementation injections at four months and teriparatide (a bone-building medication) starting at seven months. Even by 26 months after the injury, she could walk independently with a knee support but still experienced mild pain and numbness with prolonged standing. That timeline is sobering and worth knowing about if you are expecting a quick fix.

When Surgery Becomes Necessary

When conservative treatment fails or when the fracture has already progressed to surface collapse, surgical options come into play. One intermediate option is subchondroplasty, a minimally invasive procedure where a bone substitute material is injected directly into the damaged subchondral region to provide structural support. In a study of injured workers who underwent the procedure, about 86% reported marked improvement at six months, and the implant survived without needing conversion to joint replacement in 81% of cases at five years and 76% at seven years. Pain scores also dropped significantly after subchondroplasty, with preoperative pain ratings falling from about 7.6 out of 10 to under 2 within six weeks, and patient satisfaction ran at 92%.

For end-stage fractures with significant surface collapse, joint replacement becomes the necessary step. In the knee, this means either a partial (unicompartmental) or total knee replacement. Guidelines suggest that arthroplasty should be considered when the area of dead bone exceeds about 5 square centimeters, when it covers more than 40% of the affected condyle, when meniscal extrusion is 33% or greater, when the depth of the dead area exceeds 20 mm, or when there is more than 6 degrees of varus malalignment.

In the hip, the numbers are also telling. One study found that 13 out of 35 patients with subchondral insufficiency fractures of the femoral head eventually required total hip arthroplasty as pain worsened due to joint space narrowing and femoral head collapse. A separate study of young adults with subchondral fatigue fractures of the femoral head found that those whose fractures did not involve bony collapse saw their pain disappear gradually over a few months with no recurrence. But in patients where the collapse destroyed the joint surface, pain worsened progressively and surgery became unavoidable.

Biological Therapies on the Horizon

Researchers are increasingly exploring whether stem cells and other biological therapies can change the trajectory for subchondral fractures, particularly those associated with osteoarthritis. A review of the literature found evidence that several approaches, including injecting concentrated bone marrow directly into the joint, implanting it beneath the cartilage into the subchondral bone, and using scaffold materials loaded with bone marrow cells, all showed potential for improving osteoarthritis outcomes.

The route of delivery may matter. Animal research comparing injection of mesenchymal stem cells directly into the subchondral bone versus the standard approach of injecting into the joint space found that subchondral injection was at least as effective as joint injection overall, and actually superior when it came to restoring the health of the subchondral bone itself. In human patients, a prospective randomized study with an average follow-up of fifteen years found that injecting bone marrow mesenchymal stem cells into subchondral bone marrow lesions led to measurable regression of the lesion volume over 24 months.

These approaches are still largely investigational, and they are not a substitute for the established treatments described above. But they represent a shift in thinking about subchondral bone injuries, moving from simply managing symptoms and replacing joints toward trying to restore the damaged tissue itself. For patients with early subchondral damage who want to delay or avoid joint replacement, this is a space worth watching in the coming years.

Lessons from Veterinary Medicine

Subchondral bone fractures are not unique to humans. In athletic horses, particularly racehorses, fatigue injuries of the subchondral bone and calcified cartilage are well-documented. These injuries occur when the repetitive loading of galloping causes microdamage to accumulate faster than the bone can repair itself, eventually progressing to stress fractures or focal subchondral bone injuries. The equine model has been valuable for understanding the biomechanics of how these fractures develop because horses experience repetitive high-impact loading in a way that is easier to study than the varied activity patterns of humans. The underlying mechanism, microdamage outpacing repair, is the same across species. If anything, research on horse subchondral injuries has reinforced the clinical message that early detection matters: once the cycle of damage outstripping repair takes hold, the window for conservative management narrows quickly.